Acrivon Therapeutics, Inc. Common Stock - ACRV - Fundamentals

Best Investments/trading ideas for the weekJoin our free webinar on September23,2026.

Insider Tracker is here!

Try it now Watch the presentation

‌
‌

‌

Let's get started...

‌

Breakdown	2020 12/31	2021 12/31	2022 12/31	2023 12/31	2024 12/31	2025 12/31	TTM
REVENUE	0	0	0	0	0	0	--	📊
Revenue Growth (1Y)	--	--	--	--	--	--	--	📊
Revenue Growth (5Y)	--	--	--	--	--	--	--	📊
Revenue Growth (10Y)	--	--	--	--	--	--	--	📊
Cost of Revenue	0	1	1	1	1	0	-1	📊
Cost of Revenue Growth (1Y)	--	+6300.00%	+31.61%	-51.05%	+87.69%	-100.00%	--	📊
Cost of Revenue Growth (5Y)	--	--	--	--	+7638.46%	-100.00%	-173.44%	📊
Cost of Revenue Growth (10Y)	--	--	--	--	--	--	--	📊
Gross Profit	-0	-1	-1	-1	-1	0	1	📊
Gross Profit Growth (1Y)	--	-6300.00%	-31.61%	+51.05%	-87.69%	+100.00%	--	📊
Gross Profit Growth (5Y)	--	--	--	--	-7638.46%	+100.00%	+173.44%	📊
Gross Profit Growth (10Y)	--	--	--	--	--	--	--	📊
Operating Expenses	3	16	33	67	88	84	83	📊
Operating Expenses Growth (1Y)	--	+393.78%	+108.76%	+104.25%	+32.22%	-4.63%	-1.37%	📊
Operating Expenses Growth (5Y)	--	--	--	--	+2683.87%	+437.71%	+430.37%	📊
Operating Expenses Growth (10Y)	--	--	--	--	--	--	--	📊
Sell General Administrative	1	2	9	21	25	24	23	📊
Research and Development	2	14	24	45	64	60	60	📊
Other Income Expenses	0	-1	0	0	-1	0	--	📊
EBITDA	-5	-15	-30	-60	-80	-84	-88	📊
EBITDA Growth (1Y)	--	-191.16%	-95.13%	-99.03%	-32.91%	-5.74%	-5.03%	📊
EBITDA Growth (5Y)	--	--	--	--	-1402.93%	-445.80%	-473.25%	📊
EBITDA Growth (10Y)	--	--	--	--	--	--	--	📊
Depreciation and Amortization	0	1	1	1	1	0	-1	📊
Operating Income	-3	-16	-33	-67	-89	-84	-82	📊
Operating Income Growth (1Y)	--	-420.04%	-101.48%	-102.56%	-32.66%	+5.70%	+2.09%	📊
Operating Income Growth (5Y)	--	--	--	--	-2715.63%	-410.56%	-399.87%	📊
Operating Income Growth (10Y)	--	--	--	--	--	--	--	📊
Interest Expense	0	0	0	0	0	0	--	📊
Pre Tax Income	-5	-16	-31	-60	-81	-78	-77	📊
Tax Provision	0	0	0	0	0	0	--	📊
NET INCOME	-5	-16	-31	-60	-81	-78	-77	📊
Net Income Growth (1Y)	--	-206.13%	-91.88%	-93.76%	-33.40%	+3.29%	+0.82%	📊
Net Income Growth (5Y)	--	--	--	--	-1418.21%	-379.62%	-375.69%	📊
Net Income Growth (10Y)	--	--	--	--	--	--	--	📊
Basic EPS	-0.25	-0.78	-1.42	-2.74	-0.24	-2.02	-2	📊
Diluted EPS	-0.25	-0.78	-1.42	-2.74	-0.24	-2.02	-2	📊
Basic Average Shares	21	21	22	22	338	39	39	📊
Diluted Average Shares	21	21	22	22	338	39	39	📊

Breakdown

2020

12/31

2021

12/31

2022

12/31

2023

12/31

2024

12/31

2025

12/31

TTM

REVENUE

📊

Revenue Growth (1Y)

📊

Revenue Growth (5Y)

📊

Revenue Growth (10Y)

📊

Cost of Revenue

-1

📊

Cost of Revenue Growth (1Y)

+6300.00%

+31.61%

-51.05%

+87.69%

-100.00%

📊

Cost of Revenue Growth (5Y)

+7638.46%

-100.00%

-173.44%

📊

Cost of Revenue Growth (10Y)

📊

Gross Profit

-0

-1

📊

Gross Profit Growth (1Y)

-6300.00%

-31.61%

+51.05%

-87.69%

+100.00%

📊

Gross Profit Growth (5Y)

-7638.46%

+100.00%

+173.44%

📊

Gross Profit Growth (10Y)

📊

Operating Expenses

📊

Operating Expenses Growth (1Y)

+393.78%

+108.76%

+104.25%

+32.22%

-4.63%

-1.37%

📊

Operating Expenses Growth (5Y)

+2683.87%

+437.71%

+430.37%

📊

Operating Expenses Growth (10Y)

📊

Sell General Administrative

📊

Research and Development

📊

Other Income Expenses

-1

📊

EBITDA

-5

-15

-30

-60

-80

-84

-88

📊

EBITDA Growth (1Y)

-191.16%

-95.13%

-99.03%

-32.91%

-5.74%

-5.03%

📊

EBITDA Growth (5Y)

-1402.93%

-445.80%

-473.25%

📊

EBITDA Growth (10Y)

📊

Depreciation and Amortization

-1

📊

Operating Income

-3

-16

-33

-67

-89

-84

-82

📊

Operating Income Growth (1Y)

-420.04%

-101.48%

-102.56%

-32.66%

+5.70%

+2.09%

📊

Operating Income Growth (5Y)

-2715.63%

-410.56%

-399.87%

📊

Operating Income Growth (10Y)

📊

Interest Expense

📊

Pre Tax Income

-5

-16

-31

-60

-81

-78

-77

📊

Tax Provision

📊

NET INCOME

-5

-16

-31

-60

-81

-78

-77

📊

Net Income Growth (1Y)

-206.13%

-91.88%

-93.76%

-33.40%

+3.29%

+0.82%

📊

Net Income Growth (5Y)

-1418.21%

-379.62%

-375.69%

📊

Net Income Growth (10Y)

📊

Basic EPS

-0.25

-0.78

-1.42

-2.74

-0.24

-2.02

-2

📊

Diluted EPS

-0.25

-0.78

-1.42

-2.74

-0.24

-2.02

-2

📊

Basic Average Shares

338

📊

Diluted Average Shares

338

📊

Breakdown	2020 12/31	2021 12/31	2022 12/31	2023 12/31	2024 12/31	2025 12/31	TTM
REVENUE	0	0	0	0	0	0	--	📊
Revenue Growth (1Y)	--	--	--	--	--	--	--	📊
Revenue Growth (5Y)	--	--	--	--	--	--	--	📊
Revenue Growth (10Y)	--	--	--	--	--	--	--	📊
Cost of Revenue	0	1	1	1	1	0	-1	📊
Cost of Revenue Growth (1Y)	--	+6300.00%	+31.61%	-51.05%	+87.69%	-100.00%	--	📊
Cost of Revenue Growth (5Y)	--	--	--	--	+7638.46%	-100.00%	-173.44%	📊
Cost of Revenue Growth (10Y)	--	--	--	--	--	--	--	📊
Gross Profit	-0	-1	-1	-1	-1	0	1	📊
Gross Profit Growth (1Y)	--	-6300.00%	-31.61%	+51.05%	-87.69%	+100.00%	--	📊
Gross Profit Growth (5Y)	--	--	--	--	-7638.46%	+100.00%	+173.44%	📊
Gross Profit Growth (10Y)	--	--	--	--	--	--	--	📊
Operating Expenses	3	16	33	67	88	84	83	📊
Operating Expenses Growth (1Y)	--	+393.78%	+108.76%	+104.25%	+32.22%	-4.63%	-1.37%	📊
Operating Expenses Growth (5Y)	--	--	--	--	+2683.87%	+437.71%	+430.37%	📊
Operating Expenses Growth (10Y)	--	--	--	--	--	--	--	📊
Sell General Administrative	1	2	9	21	25	24	23	📊
Research and Development	2	14	24	45	64	60	60	📊
Other Income Expenses	0	-1	0	0	-1	0	--	📊
EBITDA	-5	-15	-30	-60	-80	-84	-88	📊
EBITDA Growth (1Y)	--	-191.16%	-95.13%	-99.03%	-32.91%	-5.74%	-5.03%	📊
EBITDA Growth (5Y)	--	--	--	--	-1402.93%	-445.80%	-473.25%	📊
EBITDA Growth (10Y)	--	--	--	--	--	--	--	📊
Depreciation and Amortization	0	1	1	1	1	0	-1	📊
Operating Income	-3	-16	-33	-67	-89	-84	-82	📊
Operating Income Growth (1Y)	--	-420.04%	-101.48%	-102.56%	-32.66%	+5.70%	+2.09%	📊
Operating Income Growth (5Y)	--	--	--	--	-2715.63%	-410.56%	-399.87%	📊
Operating Income Growth (10Y)	--	--	--	--	--	--	--	📊
Interest Expense	0	0	0	0	0	0	--	📊
Pre Tax Income	-5	-16	-31	-60	-81	-78	-77	📊
Tax Provision	0	0	0	0	0	0	--	📊
NET INCOME	-5	-16	-31	-60	-81	-78	-77	📊
Net Income Growth (1Y)	--	-206.13%	-91.88%	-93.76%	-33.40%	+3.29%	+0.82%	📊
Net Income Growth (5Y)	--	--	--	--	-1418.21%	-379.62%	-375.69%	📊
Net Income Growth (10Y)	--	--	--	--	--	--	--	📊
Basic EPS	-0.25	-0.78	-1.42	-2.74	-0.24	-2.02	-2	📊
Diluted EPS	-0.25	-0.78	-1.42	-2.74	-0.24	-2.02	-2	📊
Basic Average Shares	21	21	22	22	338	39	39	📊
Diluted Average Shares	21	21	22	22	338	39	39	📊

Breakdown

2020

12/31

2021

12/31

2022

12/31

2023

12/31

2024

12/31

2025

12/31

TTM

REVENUE

📊

Revenue Growth (1Y)

📊

Revenue Growth (5Y)

📊

Revenue Growth (10Y)

📊

Cost of Revenue

-1

📊

Cost of Revenue Growth (1Y)

+6300.00%

+31.61%

-51.05%

+87.69%

-100.00%

📊

Cost of Revenue Growth (5Y)

+7638.46%

-100.00%

-173.44%

📊

Cost of Revenue Growth (10Y)

📊

Gross Profit

-0

-1

📊

Gross Profit Growth (1Y)

-6300.00%

-31.61%

+51.05%

-87.69%

+100.00%

📊

Gross Profit Growth (5Y)

-7638.46%

+100.00%

+173.44%

📊

Gross Profit Growth (10Y)

📊

Operating Expenses

📊

Operating Expenses Growth (1Y)

+393.78%

+108.76%

+104.25%

+32.22%

-4.63%

-1.37%

📊

Operating Expenses Growth (5Y)

+2683.87%

+437.71%

+430.37%

📊

Operating Expenses Growth (10Y)

📊

Sell General Administrative

📊

Research and Development

📊

Other Income Expenses

-1

📊

EBITDA

-5

-15

-30

-60

-80

-84

-88

📊

EBITDA Growth (1Y)

-191.16%

-95.13%

-99.03%

-32.91%

-5.74%

-5.03%

📊

EBITDA Growth (5Y)

-1402.93%

-445.80%

-473.25%

📊

EBITDA Growth (10Y)

📊

Depreciation and Amortization

-1

📊

Operating Income

-3

-16

-33

-67

-89

-84

-82

📊

Operating Income Growth (1Y)

-420.04%

-101.48%

-102.56%

-32.66%

+5.70%

+2.09%

📊

Operating Income Growth (5Y)

-2715.63%

-410.56%

-399.87%

📊

Operating Income Growth (10Y)

📊

Interest Expense

📊

Pre Tax Income

-5

-16

-31

-60

-81

-78

-77

📊

Tax Provision

📊

NET INCOME

-5

-16

-31

-60

-81

-78

-77

📊

Net Income Growth (1Y)

-206.13%

-91.88%

-93.76%

-33.40%

+3.29%

+0.82%

📊

Net Income Growth (5Y)

-1418.21%

-379.62%

-375.69%

📊

Net Income Growth (10Y)

📊

Basic EPS

-0.25

-0.78

-1.42

-2.74

-0.24

-2.02

-2

📊

Diluted EPS

-0.25

-0.78

-1.42

-2.74

-0.24

-2.02

-2

📊

Basic Average Shares

338

📊

Diluted Average Shares

338

📊

Ex-Dividend date	--
Payment date	--
Annual Dividend	--
Dividend Yield	--
Shareholders Yield	2.04%
Next Earnings
Market cap	71.64M (USD)
EPS (TTM)	-2.00 ($)
P/E (TTM)	-0.93 ($)
Last Close	1.85

Next Earnings
Market cap	71.64M (USD)
EPS (TTM)	-2.00 ($)
P/E (TTM)	-0.93 ($)
Last Close	1.85 ($)

Ex-Dividend date	--
Payment date	--
Annual Dividend	--
Dividend Yield	--
Shareholders Yield	2.04%
Next Earnings
Market cap	71.64M (USD)
EPS (TTM)	-2.00 ($)
P/E (TTM)	-0.93 ($)
Last Close	1.85

Next Earnings
Market cap	71.64M (USD)
EPS (TTM)	-2.00 ($)
P/E (TTM)	-0.93 ($)
Last Close	1.85 ($)